Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT:NCT06511141 · RECRUITING
广告
NCT编号NCT06511141
状态RECRUITING
开始日期2024-10-22
SponsorAxonics, Inc. (INDUSTRY)
First posted
Last updated
简要摘要
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。